Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group (Q28307793)

2

0 references

Antonio Gutiérrez

3

0 references

Reyes Arranz

4

0 references

Angel León

5

0 references

Julián Marín

6

0 references

Maurizio Bendandi

7

0 references

Carmen Albo

8

0 references

María Dolores Caballero

European Journal of Haematology

9

0 references

language of work or name

English

0 references

publication date

July 2007

0 references

published in

0 references

volume

79

0 references

issue

1

0 references

page(s)

32-8

0 references

cites work

TOR, a central controller of cell growth

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2007.00856.X

Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00856.X

10.1111/J.1600-0609.2007.00856.X

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17598836

1 reference

Consolidated OpenCitations Corpus – April 2017